Vanda Pharmaceuticals Stock Market Value
| VNDA Stock | USD 5.09 0.15 3.04% |
| Symbol | Vanda |
Vanda Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vanda Pharmaceuticals. If investors know Vanda will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vanda Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.96) | Earnings Share (0.19) | Revenue Per Share 3.293 | Quarterly Revenue Growth 0.228 | Return On Assets (0.04) |
The market value of Vanda Pharmaceuticals is measured differently than its book value, which is the value of Vanda that is recorded on the company's balance sheet. Investors also form their own opinion of Vanda Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Vanda Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vanda Pharmaceuticals' market value can be influenced by many factors that don't directly affect Vanda Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vanda Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vanda Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vanda Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Vanda Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vanda Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vanda Pharmaceuticals.
| 10/26/2024 |
| 11/25/2024 |
If you would invest 0.00 in Vanda Pharmaceuticals on October 26, 2024 and sell it all today you would earn a total of 0.00 from holding Vanda Pharmaceuticals or generate 0.0% return on investment in Vanda Pharmaceuticals over 30 days. Vanda Pharmaceuticals is related to or competes with Biomarin Pharmaceutical, Vaxcyte, Liquidia Technologies, Legend Biotech, Bio Techne, Nuvation Bio, and Instil Bio. Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies t... More
Vanda Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vanda Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vanda Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 14.93 | |||
| Value At Risk | (3.67) | |||
| Potential Upside | 4.08 |
Vanda Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vanda Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vanda Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Vanda Pharmaceuticals historical prices to predict the future Vanda Pharmaceuticals' volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.45) | |||
| Treynor Ratio | (0.03) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Vanda Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Vanda Pharmaceuticals Backtested Returns
Vanda Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0171, which indicates the firm had a -0.0171% return per unit of risk over the last 3 months. Vanda Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Vanda Pharmaceuticals' Variance of 6.83, coefficient of variation of (9,437), and insignificant Risk Adjusted Performance to confirm the risk estimate we provide. The entity has a beta of 1.1, which indicates a somewhat significant risk relative to the market. Vanda Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, Vanda Pharmaceuticals is expected to follow. At this point, Vanda Pharmaceuticals has a negative expected return of -0.0445%. Please make sure to validate Vanda Pharmaceuticals' accumulation distribution, and the relationship between the potential upside and day median price , to decide if Vanda Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.38 |
Poor reverse predictability
Vanda Pharmaceuticals has poor reverse predictability. Overlapping area represents the amount of predictability between Vanda Pharmaceuticals time series from 26th of October 2024 to 10th of November 2024 and 10th of November 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vanda Pharmaceuticals price movement. The serial correlation of -0.38 indicates that just about 38.0% of current Vanda Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.38 | |
| Spearman Rank Test | -0.47 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
Vanda Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Vanda Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Vanda Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Vanda Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Vanda Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Vanda Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Vanda Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Vanda Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Vanda Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Vanda Pharmaceuticals Lagged Returns
When evaluating Vanda Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Vanda Pharmaceuticals stock have on its future price. Vanda Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Vanda Pharmaceuticals autocorrelation shows the relationship between Vanda Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Vanda Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Vanda Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vanda Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vanda Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vanda Pharmaceuticals Stock:Check out Vanda Pharmaceuticals Correlation, Vanda Pharmaceuticals Volatility and Vanda Pharmaceuticals Alpha and Beta module to complement your research on Vanda Pharmaceuticals. For information on how to trade Vanda Stock refer to our How to Trade Vanda Stock guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Vanda Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.